Get started
Author

Samantha Barratt Ross

Observed names: S. B. Ross, S. Barratt Ross, S. Ross, Samantha B Ross, Samantha B. Ross, Samantha Barratt-Ross, Samantha Ross
Observed institutions: Griffith University, Australian National University, Bond University, The University of Sydney, Garvan Institute of Medical Research, Royal Prince Alfred Hospital, Gold Coast Hospital, Centenary Institute, Amsterdam UMC Location University of Amsterdam, UNSW Sydney, Gold Coast Health, University of Amsterdam
ORCID: 0000-0003-2974-7936
Observed ORCID: 0000-0003-2974-7936
OpenAlex ID: A5058565689
Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy
2018 · Richard D. Bagnall, Jodie Ingles, et al. · Journal of the American College of Cardiology · 190
PDF
A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults
2019 · Samantha B Ross, Katherine Jones, et al. · European Heart Journal · 171
Genetic architecture of left ventricular noncompaction in adults
2020 · Samantha Barratt Ross, Emma S. Singer, et al. · Human Genome Variation · 44
PDF
Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes
2021 · Christopher Semsarian, Jodie Ingles, et al. · Journal of the American College of Cardiology · 32
PDF
Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3
2021 · Mira Holliday, Emma S. Singer, et al. · Circulation Genomic and Precision Medicine · 29
Characterization of clinically relevant copy-number variants from exomes of patients with inherited heart disease and unexplained sudden cardiac death
2020 · Emma S. Singer, Samantha B. Ross, et al. · Genetics in Medicine · 29
Burden of Recurrent and Ancestral Mutations in Families With Hypertrophic Cardiomyopathy
2017 · Samantha Barratt Ross, Richard D. Bagnall, et al. · Circulation Cardiovascular Genetics · 26
PDF
Holt-Oram syndrome in two families diagnosed with left ventricular noncompaction and conduction disease
2018 · Samantha Barratt Ross, Richard D. Bagnall, et al. · HeartRhythm Case Reports · 25
PDF
Clinical and Genetic Complexities of Left Ventricular Noncompaction
2018 · Samantha Barratt Ross, Christopher Semsarian · JAMA Cardiology · 23
Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies
2016 · Samantha Barratt Ross, Stuart T. Fraser, et al. · Trends in Cardiovascular Medicine · 22
Titin-related familial dilated cardiomyopathy: factors associated with disease onset
2025 · Renee Johnson, Robert A Fletcher, et al. · European Heart Journal · 20
PDF
Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults
2020 · Giuseppe Femia, Danyi Zhu, et al. · International Journal of Cardiology · 15
PDF
Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain ( MYH7 ) gene
2017 · Samantha Barratt Ross, Stuart T. Fraser, et al. · Stem Cell Research · 13
PDF
Left Ventricular Non-Compaction: Review of the Current Diagnostic Challenges and Consequences in Athletes
2020 · Giuseppe Femia, Christopher Semsarian, et al. · Medicina · 10
PDF
Induced pluripotent stem cell technology and inherited arrhythmia syndromes
2017 · Samantha Barratt Ross, Stuart T. Fraser, et al. · Heart Rhythm · 9
A Systematic Review and Meta-Analysis of the Prevalence of Left Ventricular Non-Compaction in Adults
2019 · S. Ross, C. Semsarian, et al. · Heart Lung and Circulation · 8
PDF
Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy
2024 · Seakcheng Lim, Melissa M. Mangala, et al. · Disease Models & Mechanisms · 7
Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy
2023 · Henrietta Cserne Szappanos, Helena M. Viola, et al. · Scientific Reports · 7
PDF
Characterization of the first induced pluripotent stem cell line generated from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia due to a heterozygous mutation in cardiac calsequestrin-2
2019 · Samantha Ross, Mira Holliday, et al. · Stem Cell Research · 7
PDF
Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation
2018 · Mira Holliday, Samantha Barratt Ross, et al. · Stem Cell Research · 7
PDF
Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy
2017 · Samantha Barratt Ross, Stuart T. Fraser, et al. · Stem Cell Research · 7
PDF
Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln
2018 · Mira Holliday, Samantha Barratt Ross, et al. · Stem Cell Research · 5
PDF
Overdiagnosis of left ventricular non-compaction in adults: the data tells the story
2019 · Samantha B Ross, Kevin McGeechan, et al. · European Heart Journal · 4
Time to Reconsider the Diagnosis of “Left Ventricular Noncompaction” in Adults?
2021 · Samantha Barratt Ross, Alexandra Barratt, et al. · Heart Lung and Circulation · 3
Generation of an isogenic CRISPR/Cas9-corrected control induced pluripotent stem cell line from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia with a heterozygous variant in cardiac calsequestrin-2
2024 · Ginell N. Ranpura, Mira Holliday, et al. · Stem Cell Research · 1
Works count: 41
Citation count: 717
H-index: 13
I10-index: 14
Year
Topic
Type